Quintiles Transitional Holdings Inc. (NYSE:Q) – Stock analysts at William Blair cut their Q3 2018 earnings per share (EPS) estimates for Quintiles Transitional Holdings in a research report issued to clients and investors on Wednesday. William Blair analyst J. Kreger now expects that the medical research company will post earnings per share of $1.34 for the quarter, down from their previous forecast of $1.37. William Blair currently has a “Outperform” rating and a $93.42 target price on the stock. William Blair also issued estimates for Quintiles Transitional Holdings’ FY2018 earnings at $5.29 EPS and FY2019 earnings at $6.05 EPS.
Quintiles Transitional Holdings (NYSE:Q) last announced its quarterly earnings results on Thursday, October 26th. The medical research company reported $1.19 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.14 by $0.05. Quintiles Transitional Holdings had a return on equity of 12.60% and a net margin of 0.58%. The business had revenue of $2.02 billion for the quarter, compared to analyst estimates of $2.01 billion. During the same quarter in the prior year, the company posted $1.00 EPS. The company’s quarterly revenue was up 77.6% on a year-over-year basis. TRADEMARK VIOLATION WARNING: This piece was first posted by Markets Daily and is the property of of Markets Daily. If you are accessing this piece on another website, it was copied illegally and reposted in violation of international trademark and copyright laws. The correct version of this piece can be viewed at https://www.themarketsdaily.com/2017/11/14/quintiles-transitional-holdings-inc-to-post-q3-2018-earnings-of-1-34-per-share-william-blair-forecasts-q.html.
Q has been the topic of several other research reports. BidaskClub downgraded Quintiles Transitional Holdings from a “strong-buy” rating to a “buy” rating in a report on Friday, August 11th. Zacks Investment Research upgraded Quintiles Transitional Holdings from a “hold” rating to a “buy” rating and set a $101.00 price target on the stock in a report on Thursday, July 27th. Barclays PLC set a $100.00 price target on Quintiles Transitional Holdings and gave the stock a “buy” rating in a report on Friday, August 4th. Argus upped their price target on Quintiles Transitional Holdings from $98.00 to $104.00 and gave the stock a “buy” rating in a report on Monday, September 18th. Finally, KeyCorp restated a “buy” rating and set a $100.00 price target on shares of Quintiles Transitional Holdings in a report on Sunday, September 24th. Eleven equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $103.15.
Shares of Quintiles Transitional Holdings (NYSE:Q) traded down $1.14 during trading on Monday, hitting $102.91. The stock had a trading volume of 1,532,500 shares, compared to its average volume of 1,501,492. Quintiles Transitional Holdings has a twelve month low of $71.90 and a twelve month high of $110.67. The firm has a market cap of $21,987.17, a price-to-earnings ratio of 23.76, a PEG ratio of 1.73 and a beta of 0.65. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 1.29.
In other news, major shareholder Cpp Investment Board Private H sold 5,218,245 shares of the firm’s stock in a transaction on Monday, August 28th. The stock was sold at an average price of $97.33, for a total transaction of $507,891,785.85. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Dennis B. Ph D. Gillings sold 968,023 shares of the firm’s stock in a transaction on Monday, August 28th. The stock was sold at an average price of $97.33, for a total value of $94,217,678.59. Following the sale, the director now owns 9,071,839 shares in the company, valued at approximately $882,962,089.87. The disclosure for this sale can be found here. Insiders sold a total of 14,175,702 shares of company stock valued at $1,361,299,848 over the last ninety days. 6.40% of the stock is currently owned by company insiders.
Institutional investors have recently modified their holdings of the stock. Sun Life Financial INC acquired a new position in Quintiles Transitional Holdings in the third quarter valued at $106,000. Fiduciary Trust Co. acquired a new position in Quintiles Transitional Holdings in the second quarter valued at $105,000. Korea Investment CORP boosted its holdings in Quintiles Transitional Holdings by 142.5% in the second quarter. Korea Investment CORP now owns 1,370 shares of the medical research company’s stock valued at $123,000 after acquiring an additional 805 shares during the last quarter. GWM Advisors LLC acquired a new position in Quintiles Transitional Holdings in the second quarter valued at $122,000. Finally, Citigroup Inc. boosted its holdings in Quintiles Transitional Holdings by 15.5% in the second quarter. Citigroup Inc. now owns 1,858 shares of the medical research company’s stock valued at $167,000 after acquiring an additional 250 shares during the last quarter. Hedge funds and other institutional investors own 94.04% of the company’s stock.
Quintiles Transitional Holdings Company Profile
Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.